In June 2024, we joined Petauri, a purpose-built pharmaceutical services platform combining best-in-class companies with recognised expertise in global market access, medical affairs, patient services, and data and analytics. As part of the Petauri platform, we now collaborate directly with colleagues in the US and Europe, with a broad range of specialisms, all working to improve patient access.
When we joined the Petauri platform, we did so alongside Delta Hat, a team recognised and respected by many of our clients. In the coming weeks, the Mtech Access and Delta Hat teams, along with a US-based team focused on HEOR and evidence strategy services, will unite under one Petauri brand.
At Mtech Access, we have expert teams that support each stage of the global market access and HEOR journey, from strategy to implementation. Delta Hat bring in-depth expertise in solving health economics and statistical challenges. Together with our US market experts, we combine these strengths to offer comprehensive support to above- and within-market teams. Why would you ever need another partner?
What this means for our clients:
Enhanced services: This strategic move will allow us to offer greater breadth and depth of technical and consulting experience, as well as market coverage for our clients.
Continuity and stability: The quality of work and client service that you have come to expect, along with your current projects and relationships, will remain unchanged.
Innovative solutions: Leveraging the strengths of the Petauri group, we will build on our commitment to growth and innovation in Pharma and Medtech commercialisation.
